South of the Border: Sanofi’s Tailored Approach To Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi’s recent acquisition of Medley, Brazil’s leading generics manufacturer, reflects its strategy of going local — and generic — in emerging markets.
You may also be interested in...
Sanofi CSO David-Alexandre Gros On The Next Wave Of Growth In Emerging Markets: An Interview With PharmAsia News
During a visit to Shanghai, Sanofi’s chief strategy officer sits down to talk about the company’s playbook for emerging markets, which focuses on both the BRIC countries and up-and-coming markets like Vietnam, Colombia and Nigeria.
Watson Takes Stake In Brazil's Moksha8
The Sao Paolo-based company will market about a dozen of Watson's generics in Mexico and Brazil, with potential for more.
Watson Takes Stake In Brazil's Moksha8
The Sao Paolo-based company will market about a dozen of Watson's generics in Mexico and Brazil, with potential for more.